文献速递消化道肿瘤与早癌消化内镜

粪便免疫化学检测阳性患者结肠镜检查时间与结直肠癌风险

Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-11-01

本研究基于2004至2012年台湾全国筛查计划中39,346例粪便免疫化学检测(FIT)阳性且超过1个月完成结肠镜检查的50-69岁患者,分析任何结直肠癌(CRC)及晚期CRC(III-IV期)风险与随访延迟的关系。结果显示,与1-3个月内结肠镜检查相比,延迟超过6个月和超过12个月时任何CRC及晚期CRC风险均显著升高,而3-6个月延迟无显著差异。结论提示FIT阳性后及时结肠镜检查的重要性。

要点

  • FIT阳性后结肠镜检查延迟超过6个月,任何CRC风险显著升高(aOR 1.31,95%CI 1.04-1.64)。
  • 延迟超过6个月,晚期CRC风险显著升高(aOR 2.09,95%CI 1.43-3.06)。
  • 延迟3-6个月与1-3个月相比,任何CRC及晚期CRC风险无显著差异。

核心结论

  • FIT阳性患者中,结直肠癌及晚期结直肠癌风险随结肠镜检查延迟时间增加而升高,及时结肠镜检查很重要。

研究设计与样本

  • 研究收集2004至2012年台湾全国筛查计划中39,346例50-69岁FIT阳性且超过1个月完成结肠镜检查的患者数据。
  • 采用逻辑回归模型评估任何CRC及晚期CRC(III-IV期)风险,结果以调整比值比(aOR)及95%CI表示。

主要发现

  • 队列中2,003例诊断为任何CRC,445例为晚期疾病。
  • 与1-3个月内结肠镜检查(每1000例患者中任何CRC 50例、晚期疾病11例)相比,延迟超过6个月时任何CRC风险显著升高(aOR 1.31;95%CI 1.04-1.64;每1000例患者68例),晚期疾病风险显著升高(aOR 2.09;95%CI 1.43-3.06;每1000例患者24例)。
  • 延迟超过12个月时任何CRC风险进一步升高(aOR 2.17;95%CI 1.44-3.26;每1000例患者98例),晚期疾病风险进一步升高(aOR 2.84;95%CI 1.43-5.64;每1000例患者31例)。
  • 3-6个月随访结肠镜检查与1-3个月相比,任何CRC风险无显著差异(aOR 0.98;95%CI 0.86-1.12;每1000例患者49例),晚期疾病风险无显著差异(aOR 0.95;95%CI 0.72-1.25;每1000例患者10例)。

临床怎么用

  • 原文结论指出这些发现表明FIT阳性后及时结肠镜检查的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In patients with positive results from a fecal immunochemical test (FIT), failure to receive a timely follow-up colonoscopy may be associated with higher risks of colorectal cancer (CRC) and advanced-stage CRC. We evaluated the prevalence of any CRC and advanced-stage CRC associated with delays in follow-up colonoscopies for patients with positive results from a FIT. METHODS: We collected data from 39,346 patients (age, 50-69 years) who participated in the Taiwanese Nationwide Screening Program from 2004 through 2012 and had completed a colonoscopy more than 1 month after a positive result from a FIT. Risks of any CRC and advanced-stage CRC (stage III-IV) were evaluated using logistic regression models and results expressed as adjusted odds ratios (aORs) and corresponding 95% CIs. RESULTS: In our cohort, 2003 patients received a diagnosis of any CRC and 445 patients were found to have advanced-stage disease. Compared with colonoscopy within 1-3 months (cases per 1000 patients: 50 for any CRC and 11 for advanced-stage disease), risks were significantly higher when colonoscopy was delayed by more than 6 months for any CRC (aOR, 1.31; 95% CI, 1.04-1.64; 68 cases per 1000 patients) and advanced-stage disease (aOR, 2.09; 95% CI, 1.43-3.06; 24 cases per 1000 patients). The risks continuously increased when colonoscopy was delayed by more than 12 months for any CRC (aOR, 2.17; 95% CI, 1.44-3.26; 98 cases per 1000 patients) and advanced-stage disease (aOR, 2.84; 95% CI, 1.43-5.64; 31 cases per 1000 patients). There were no significant differences for colonoscopy follow up at 3-6 months for risk of any CRC (aOR, 0.98; 95% CI, 0.86-1.12; 49 cases per 1000 patients) or advanced-stage disease (aOR, 0.95; 95% CI, 0.72-1.25; 10 cases per 1000 patients). CONCLUSIONS: In an analysis of data from the Taiwanese Nationwide Screening Program, we found that among patients with positive results from a FIT, risks of CRC and advanced-stage disease increase with time. These findings indicate the importance of timely colonoscopy after a positive result from a FIT.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lee YC, Fann JC, Chiang TH, et al. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests. Clin Gastroenterol Hepatol. 2018. PMID: 30391435. doi:10.1016/j.cgh.2018.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。